2002
DOI: 10.1053/jcpa.2001.0544
|View full text |Cite
|
Sign up to set email alerts
|

Pathological and Immunohistochemical Studies of Choroid Plexus Carcinoma of the Dog

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

6
44
2

Year Published

2004
2004
2016
2016

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(52 citation statements)
references
References 13 publications
6
44
2
Order By: Relevance
“…The reason for the negative finding for GFAP in canine cases is unknown. In the present case, immunoreactivity for vimentin was slightly positive, which was the same as findings reported in other animals [2,6,10,12]. The immunoreactivity for cytokeratin was also slightly positive in the present case, while was negative in the control dog.…”
supporting
confidence: 92%
See 1 more Smart Citation
“…The reason for the negative finding for GFAP in canine cases is unknown. In the present case, immunoreactivity for vimentin was slightly positive, which was the same as findings reported in other animals [2,6,10,12]. The immunoreactivity for cytokeratin was also slightly positive in the present case, while was negative in the control dog.…”
supporting
confidence: 92%
“…Immunohistochemistry was performed with labeled streptavidin-biotin (LSAB) method. Rabbit antisera against human glial fibrillary acidic protein (GFAP, prediluted, Dako, Glostrup, Denmark), and mouse monoclonal antibodies against human epidermal keratin (cytokeratin AE1/AE3, 1:20, Dako, Carpinteria, CA) [2] and bovine vimentin (1:20, Chemicon, Temecula, CA) were used as primary antibodies. The reaction products were visualized using the peroxidase and 3,3'-diaminobenzidine system.…”
mentioning
confidence: 99%
“…4 In addition to the previously mentioned markers, an earlier study examined epithelial cell adhesion molecule (EpCAM), epithelial membrane antigen, carcinoembryonic antigen, proliferating cell nuclear antigen, S100, vimentin, and MIB-1, none of which showed consistent immunoreactivity against choroid plexus and derived tumors. 1 In human pathology, multiple studies have been performed to identify specific immunomarkers for CPTs to differentiate against metastatic carcinomas of the brain. 2,13 Of the markers that have been explored, Kir7.1 has been demonstrated to be a reliable marker for CPTs.…”
mentioning
confidence: 99%
“…Metastasis and invasion along the neuraxis should be used as diagnostic criterion for malignancy of choroid plexus neoplasms (KOESTNER et al, 1999). In dogs, this neoplasm metastatize frequently within the ventricular spaces or the meninges (CANTILE et al, 2002). In the present case, high mitotic index, marked cellular pleomorfism, extensive areas of necrosis and hemorrhage and the occurrence of tumor cells in the pituitary similar to those found in the brain tumor were considered critical in favoring the diagnosis of CPC.…”
Section: Palavras-chave: Doenças De Bovinos Neoplasmas Neuropatologiamentioning
confidence: 65%